Shuttle Pharmaceuticals Holdings, Inc. — Cyborg Score 5/10
Mixed
AI-enabled oncology drug discovery
Strategic Profile
As a discovery and development stage specialty pharmaceutical company, Shuttle is focused on improving outcomes for cancer patients treated with radiation therapy. The company has been awarded patents for its radiation sensitizing HDAC inhibitor technology platform, which reduces side effects for cancer patients treated with radiation therapy.
Cyborg Score Rationale
Pre-revenue clinical-stage biotech with differentiated AI-driven drug discovery platform and patent-protected HDAC inhibitor technology. However, early financial data shows minimal liquidity runway, significant accumulated losses, and post-IPO volatility, posing execution and funding risks.
Top Insights
Molecule.ai platform combines AI with structured workflows for molecular discovery, addressing drug development efficiency bottlenecks
Patent portfolio includes US and Hong Kong grants for radiation sensitizing HDAC inhibitors; European applications under review
IPO in August 2025 provided capital but stock has experienced extreme post-IPO volatility (44%+ swings), reflecting biotech execution risks
Clinical-stage focus means revenue model and cash burn rate represent key near-term watch factors
Named Competitors
HDAC Inhibitor Programs — Large pharma with oncology portfolio including HDAC inhibitors
Oncology Portfolio — Diversified pharma with radiation oncology and cancer therapeutics focus
Exscientia — AI-driven drug discovery platform focused on molecular design
Atomwise — AI platform for molecular discovery and virtual screening
Recent Developments
(August 2025) Completed IPO on NASDAQ, initially surging over 300% before experiencing volatility
(Early 2024) Hold ~$1.4M cash and ~$2.8M marketable securities with accumulated deficit of ~$17.2M as of Q1 2024
Open the full interactive Shuttle Pharmaceuticals Holdings, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.